Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan: NexImmune, Inc. (NEXI)
The development of NexImmune, Inc. (NEXI) relies on the validation of T-cell efficacy and interest from pharmaceutical behemoths. The quarterly EPS growth rate shows a sharp decline, driven by a loss of operational activity and the depletion of remaining capital. Previously, the AIM platform established patent protection via nanostructures, but currently, the value of 0.00 reflects the metric level amid a complete business restructuring.
Rincian metrik komprehensif lan analitis neximmune.com (NEXI)
- rega saham lan prakiraan rega para ahli:
- indikator kapitalisasi bursa perusahaan:
- data kapitalisasi buku:
- rincian utang lan likuiditas:
Utang marang Ekuitas NexImmune, Inc.|NEXI - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas NexImmune Corporation|NEXI - Utang kumulatif perusahaan|Utang marang nilai buku NexImmune|NEXI - Tanggungan jangka dawa|Kewajiban jangka cendhak perusahaan NexImmune|Rasio cepet neximmune.com
- rincian bathi lan kelipatan pasar:
NEXI - Bathi pungkasan|Proyeksi bathi mangsa ngarep NexImmune, Inc.|NEXI - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep NexImmune, Inc.|NEXI - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA NexImmune Corporation|NEXI - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan NexImmune|NEXI - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan neximmune.com|NEXI - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep NexImmune, Inc.
- data pendapatan lan penerimaan dodolan:
Analisis komprehensif perusahaan:NexImmune Inc, NEXI
NexImmune, Inc. (NEXI) is advancing pharmaceutical developments amidst geopolitical risks impacting supply chains and patent protection. Analyzing the current quarterly EPS pace allows for an assessment of net income per share dynamics based on 10-Q reports, excluding random spikes; such a smoothed revenue trajectory is critical for distinguishing sustainable growth from temporary factors, preventing investment in weak assets.
Pesaing NexImmune, Inc.
IBRX: Wutah bathi EPS kuartalan|IMCR - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan januxrx.com|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan arcusbio.com (RCUS)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Zymeworks Inc (ZYME)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Tango Pharma TNGX|Iovance Biotherapeutics Inc - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan Immatics Biotechnologies IMTX|XNCR - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|CMPX (compasstherapeutics.com) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|Replimune Inc. (REPL) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Lyell Immunopharma Inc (LYEL)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan IPHA|PYXS - Wutah bathi resik saben saham sajroning taun lumaku|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan CGEN (Compugen Ltd.)|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan IOBT|Wutah bathi EPS kuartalan STRO (Sutro Biopharma)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan INKT|Werewolf - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Immix Biopharma|ALX Oncology (ALXO) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|cuebiopharma.com (CUE) - Wutah bathi EPS kuartalan|PDSB (PDS Biotechnology Corp) - Wutah bathi EPS kuartalan|Wutah bathi EPS kuartalan sonnetbio.com|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan MAIA Biotechnology, Inc. (MAIA)|LIMN: Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|LAVA Therapeutics - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|nextcure.com (NXTC) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|LPTX - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Intensity Therapeutics, Inc. INTS|SNSE: Wutah bathi EPS kuartalan|Synthetic Biologics - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|GRTS (Gritstone bio) - Wutah bathi EPS kuartalan|KA (Kineta, Inc.) - Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Turnstone Biologics Corporation (TSBX)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Vaccinex VCNX|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan harpoontx.com HARP
